Eikon Therapeutics, Inc. Common Stock (EIKN) vs REGENXBIO Inc. (RGNX)
A side-by-side comparison of Eikon Therapeutics, Inc. Common Stock and REGENXBIO Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EIKN
Eikon Therapeutics, Inc. Common Stock
$7.51HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
RGNX
REGENXBIO Inc.
$7.45HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — EIKN vs RGNX
growth of $100 · dividends reinvested · last 1yEIKN -49.7% (-49.7%/yr)RGNX -27.8% (-27.8%/yr)RGNX compounded faster over this window
EIKN RGNX
EIKN vs RGNX: by the numbers
- •EIKN is the larger company ($407M vs $385M market cap).
- •Both run net losses; EIKN's is the smaller (0.00% vs -112.58% net margin).
Metrics side by side
Valuation
| Metric | EIKN | RGNX |
|---|---|---|
| P/S ratio | N/A | 2.21 |
| P/B ratio | 0.87 | 5.37 |
Profitability
| Metric | EIKN | RGNX |
|---|---|---|
| Gross margin | 0.00% | 88.09% |
| Operating margin | 0.00% | -94.08% |
| Net margin | 0.00% | -112.58% |
| ROE | -69.06% | -273.72% |
| ROIC | -46.16% | -54.00% |
Growth (annualized)
| Metric | EIKN | RGNX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 1.59% |
| Total return CAGR (5Y) | N/A | -24.15% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.